AI-generated summary
The authors report a pilot randomised controlled trial in which premature neonates received 670 nm red light daily for 15 minutes or no red light. They found no difference in severity of retinopathy of prematurity or need for laser treatment between groups, and survival was 100% in the treated group versus 89% in the untreated group, a difference that was not statistically significant. The authors note the trial was a pilot and that dosage and delivery require further testing.
- Participants
- 86
- Who or what was studied
- Neonates born at less than 30 weeks gestation or weighing less than 1150 g
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The abstract describes a small pilot trial, the survival difference did not reach statistical significance, and the authors state further dosage and delivery testing is required.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
- Energy density (fluence)
- 9 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.